A systematic review of 3D printing of pharmaceutical drug products: Barriers and enablers

Elton Gatt, Nicolette Sammut Bartolo, Lilian M Azzopardi

Open source

DOI
10.1016/j.ejpb.2026.115211
Published
2026-10
Container
European Journal of Pharmaceutics and Biopharmaceutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejpb.2026.115211,
  title = {A systematic review of 3D printing of pharmaceutical drug products: Barriers and enablers},
  author = {Elton Gatt and Nicolette Sammut Bartolo and Lilian M Azzopardi},
  year = {2026},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  doi = {10.1016/j.ejpb.2026.115211},
  url = {https://doi.org/10.1016/j.ejpb.2026.115211}
}

RIS

TY  - JOUR
TI  - A systematic review of 3D printing of pharmaceutical drug products: Barriers and enablers
AU  - Elton Gatt
AU  - Nicolette Sammut Bartolo
AU  - Lilian M Azzopardi
PY  - 2026
JO  - European Journal of Pharmaceutics and Biopharmaceutics
DO  - 10.1016/j.ejpb.2026.115211
UR  - https://doi.org/10.1016/j.ejpb.2026.115211
ER  - 

APA

Gatt, E., Bartolo, N. S., & Azzopardi, L. M. (2026). A systematic review of 3D printing of pharmaceutical drug products: Barriers and enablers. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115211

Source records